{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"Patients will receive sunitinib by mouth once a day. Treatment may continue for as long as benefit is shown.\n\nsunitinib malate: Given orally","id":"OG000","title":"Arm I"}],"populationDescription":"Data were not collected","reportingStatus":"POSTED","timeFrame":"At 6 months and 1 year","title":"Progression-free Survival","type":"SECONDARY"}